The indexs of apoptosis in thermotherapy,chemotherapy and thermochemotherapy groups were18.96±2.54,20.05±3.64,36.62±8.96respectively and significantly larger than that in the control group(4.68±1.68).
Results The tumors weights in thermotherapy,chemo-therapy and thermochemotherapy groups were(1.95±0.34)g,(1.86±0.40)g and(1.09±0.21)g respectively,and significantlylighter than that in control group(P<0.001).
Methods:Inhibition ratio to human pulmonal giant cell carcinoma cells(PLA-801D)of the group of 42℃ hyperthermia treatment,chemical treatment with NVB and hyperthermia-chemical combined treatment were assayed by the method of MTT.
Methods Inhibition ratio to human pulmonal giant cell carcinoma cells(PLA-801D) of the groups of 42℃ hyperthermia treatment,chemical treatment with DDP and hyperthermia-chemical combined treatment were assayed by the method of MTT.
Temperature measure in hyperthermia treatment is for controlling the temperature of the tumor, and the temperature of the tumor can be kept that for hyperthermia treatment.
Objective:To investigate the effects of hyperthermia combined with taxol on human lung cell line A549 so that to provide the possible guidance for the chemo hyperthermia therapy with taxol.
Quercetin completely inhibited the synthesis and intracellular accumulation of 70-kD heat shock protein (HSP70) in response to hyperthermia or to treatment with sodium arsenite, whereas dihydroquercetin in the same or higher doses had no such effect.
This review compares high- and lowenergy transurethral microwave thermotherapy (TUMT) and transurethral needle ablation (TUNA) of the prostate with TURP in clinical efficacy and safety.
This review article discusses microwave thermotherapy as such an option and reports the long-term experience with the CoreTherm (CoreTherm Operations AB, Sweden) device.
This paper presents a heat transfer model for the hyperthermia treatment of cervix cancer using a intracavitary microwave applicator and based on which the 3-D finite element simulation of the temperature fields have done.
A total of 95 patients suffering from prostatic symptoms due to benign hyperplasia (BPH) and scheduled for surgery elected to participate in a clinical trial of local hyperthermia therapy to the prostate.
A total of 114 patients suffering from prostatic symptoms due to benign hyperplasia (BPH) and scheduled for surgery elected to participate in a clinical trial of local hyperthermia therapy to the prostate.
Finally, as an application demonstration, we apply the fuzzy PI controller to control issue temperature, in computer simulation, during hyperthermia therapy.